Neurogene Inc NGNE
News
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Neurogene to Participate in Upcoming Investor Conferences
Neurogene Presents New Data at ESGCT Congress that Reinforce Key Differentiators of NGN-401 Gene Therapy for Rett Syndrome
Neurogene Announces Upcoming Presentations Highlighting Key Differentiators of NGN-401 for Rett Syndrome at the ESGCT 33rd Annual Congress
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)